![](https://umdaa.co/assets/uploads/default/Surgical Oncology.jpg)
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
This is an open-label, randomized, controlled, phase 3 trial done at 29 hospitals in China. Patients had pathologically confirmed HER2-positive metast...
![](https://umdaa.co/assets/uploads/default/Neurology.jpg)
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
In 2020, mean weekly radiotherapy courses fell by 19% in April, 6% in May, and 11% in June compared with corresponding months in 2019. The largest red...